Placental abnormalities detected by ultrasonography in a case of confined placental mosaicism for trisomy 2 with severe fetal growth restriction

J Obstet Gynaecol Res. 2014 Jan;40(1):279-83. doi: 10.1111/jog.12145. Epub 2013 Sep 5.

Abstract

Clinical outcome of confined placental mosaicism (CPM) is varied, from normal pregnancy to intrauterine fetal death. It has been suggested that CPM for trisomy 2 is less likely to cause serious adverse effect on pregnancy. We hereby report a case of CPM for trisomy 2, which presented severe fetal growth restriction (FGR) and placental abnormalities. A 30-year-old woman was referred to our hospital at 17⁺² weeks because of marked FGR. Ultrasonography demonstrated prominent placental hypertrophy with multiple focal defects without any fetal structural abnormalities. Amniocentesis at 18⁺³ weeks revealed normal karyotype. Fetal growth rate worsened with gestational weeks, reaching -7 standard deviation at 36 weeks. At 37 weeks, the fetal condition suddenly deteriorated, ending in a stillbirth of a 756-g female baby. Postnatal cytogenetic analysis by array comparative genomic hybridization revealed trisomy 2 of the chorionic villi, and CPM for trisomy 2 was suggested as the cause of FGR and placental abnormalities.

Keywords: array comparative genomic hybridization; confined placental mosaicism; fetal growth restriction; trisomy 2; ultrasound.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Chromosomes, Human, Pair 2*
  • Female
  • Fetal Development
  • Fetal Growth Retardation / etiology*
  • Humans
  • Hypertrophy
  • Mosaicism*
  • Placenta / diagnostic imaging*
  • Placenta / pathology
  • Placenta Diseases / diagnostic imaging*
  • Placenta Diseases / genetics
  • Placenta Diseases / pathology
  • Placenta Diseases / physiopathology
  • Placentation*
  • Pregnancy
  • Severity of Illness Index
  • Stillbirth
  • Trisomy*
  • Ultrasonography